A*STAR Genome Institute of Singapore (A*STAR GIS)

A*STAR researchers devise a new streamlined method for analysing thousands of genes at once on a tissue-wide scale, offering a more accessible tool to study and diagnose diseases at a cellular level.

A new RNA sequencing approach allows scientists to hone in on rare, often obscured transcripts that reflect the finer details of cellular function.

Through innovative technologies and deep biological insights, A*STAR research institutes and ecosystem partners aim to enhance the healthspan of Asia’s ageing populations.

A*STAR researchers develop a new method to study RNA’s intricate folding patterns within a single cell, revealing fresh insights into how cells develop and function.

Bambu, a new computational tool for analysing genetic data, effectively identifies and quantifies complex gene patterns.

Advanced DNA sequencing technologies reveal little trace of native microbial communities in healthy human blood, challenging recent claims to the contrary.

The A*STAR researchers in NRF Singapore’s class of 2024.

Researchers identify predictive immune ‘signatures’ in liver cancer patients that can help tailor and improve the success rates of combined immunotherapy and radiotherapy.

Researchers performed a comprehensive genetic sequencing of individual tumour cells to refine existing colorectal cancer classifications.

By contributing deep insights to Singapore’s innovation ecosystem, A*STAR initiatives are helping to build strategic relationships with international partners and bridge the gaps in local capabilities.

A programmable gene editing tool targets and eliminates a rapidly mutating RNA virus responsible for hand, foot and mouth disease.

From molecular methods to advanced optics, scientists are combining techniques and expertise from diverse disciplines to transform skin health research and fortify the body’s outermost barrier.